5 results on '"Vishal Kukkar"'
Search Results
2. Intercostal Artery Aneurysmosis Secondary to Chronic Cocaine Abuse
- Author
-
Amit Agarwal, Vishal Kukkar, and Kanupriya Vijay
- Subjects
Cardiac/Thoracic/Vascular Surgery ,General Engineering ,cardiovascular system ,aneurysm ,artery ,cocaine ,intercostal ,cardiovascular diseases ,Radiology ,abuse - Abstract
Intercostal artery aneurysms are rare entities usually seen in connective tissue disorders and inflammatory conditions and syndromes like Ehlers-Danlos syndrome, Kawasaki’s disease, and neurofibromatosis. Spontaneous development of intercostal aneurysm is rare and the presence of multiple aneurysms/aneurysmosis is exceedingly rare. Although there have been a few case reports on aortic aneurysm, coronary artery aneurysms and many on ruptured cerebral aneurysms, we could not find a single case of spontaneous intercostal artery aneurysm secondary to chronic cocaine abuse. We report an exceedingly rare case of intercostal artery aneurysmosis presumably secondary to long-term cocaine abuse. Intercostal artery aneurysm is the least common visceral aneurysm and given the very limited literature on this subject, the pathogenesis is poorly understood.
- Published
- 2022
3. The Role of Propionibacterium acnes in the Pathogenesis of Sarcoidosis and Ulcerative Colitis: How This Connection May Inspire Novel Management of These Conditions
- Author
-
Bilal Haider Malik, Srikala Kambampati, Vishal Kukkar, Shehnaz Wasim, and Sirisha Sakhamuru
- Subjects
medicine.medical_specialty ,innate immune system ,Dermatology ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Inflammatory bowel disease ,propionibacterium acnes ,03 medical and health sciences ,Propionibacterium acnes ,0302 clinical medicine ,inflammatory bowel disease ,Internal Medicine ,medicine ,sarcoidosis ,Isotretinoin ,Acne ,ulcerative colitis ,biology ,business.industry ,Gastroenterology ,hidradenitis suppurativa ,General Engineering ,isotretinoin ,Immune dysregulation ,medicine.disease ,biology.organism_classification ,Ulcerative colitis ,cutibacterium acnes ,toll-like receptors ,noncaseating granuloma ,Sarcoidosis ,business ,030217 neurology & neurosurgery ,Pyoderma gangrenosum ,medicine.drug - Abstract
A lesser-acknowledged role of Propionibacterium acnes is its effect on the development of sarcoidosis. This literature review not only further explores this association but also that of Propionibacterium acnes and other inflammatory conditions, such as ulcerative colitis and pyoderma gangrenosum, acne, ulcerative colitis syndrome (PAC syndrome). This article reviews the effect that isotretinoin, a commonly used treatment of acne, has on the pathogenesis of ulcerative colitis, and the immune dysregulation and genetic susceptibility of individuals prone to developing acne, sarcoidosis, and ulcerative colitis. Literature for this article review was obtained from PubMed by utilizing both regular keywords and medical subject heading (MeSH) subheadings for data gathering. Regular keywords were: Propionibacterium acnes, sarcoidosis, ulcerative colitis, and isotretinoin. MeSH subheadings used were: Propionibacterium acnes/immunology, Propionibacterium acnes/pathogenicity, Propionibacterium acnes/genetics, sarcoidosis/immunology, and sarcoidosis/genetics. Following the application of inclusion and exclusion criteria, a total of 5172 publications were obtained. A total of 5086 publications were removed due to a lack of relevancy to outcomes of interest. The remaining 86 publications from all the regular and MeSH keywords were selected due to relevancy to outcomes of interest. Following this, a refined manual search was done, with the removal of duplicates, and 33 publications from PubMed were selected for review. Following a review of these records, Propionibacterium acnes was repeatedly concluded to be a causative agent of sarcoidosis. Variable results for the association between Propionibacterium acnes and ulcerative colitis were found. Most studies showed no significant association between the use of isotretinoin and the development of ulcerative colitis. A strong overlapping role of genetic susceptibility and immune dysregulation in the pathogeneses of sarcoidosis, ulcerative colitis, and Propionibacterium acnes was found.
- Published
- 2020
- Full Text
- View/download PDF
4. Neuroprotective and Neurodegenerative Aspects of Coffee and Its Active Ingredients in View of Scientific Literature
- Author
-
Bilal Haider Malik, Sirisha Sakhamuru, Shehnaz Wasim, Vanessa M Awad, and Vishal Kukkar
- Subjects
Parkinson's disease ,Disease ,030204 cardiovascular system & hematology ,Neuroprotection ,neurodegenerative disesase ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Dementia ,Cognitive decline ,Amyotrophic lateral sclerosis ,alzheimers disease ,Depression (differential diagnoses) ,caffeine ,Psychiatry ,coffee consumption ,business.industry ,General Engineering ,cognitive decline ,medicine.disease ,stroke ,Neurology ,chemistry ,parkinson's disease ,Public Health ,Caffeine ,business ,Neuroscience ,030217 neurology & neurosurgery ,dementia - Abstract
Coffee and its components have several neuroprotective properties that lower the risk of cognitive decline and other neurodegenerative diseases. This study reviews the mechanisms by which coffee and its respective compounds affect the brain and its pathologies. Many epidemiological studies in this literature review have shown coffee to reduce the risk of developing dementia, stroke, and Alzheimer's disease. It may also have a positive impact on the disease course of amyotrophic lateral sclerosis, Parkinson's disease, and depression. The optimal benefits achieved from coffee in these pathologies rely on higher daily doses. Most of its effects are attributed to caffeine by the antagonism of adenosine receptors in the central nervous system; however, other coffee constituents like chlorogenic acids have also shown much promise in therapeutic value. Existing research considers coffee to have great potential, but additional studies are still needed to clarify the mechanisms and actual causal relationships in certain neuropathologies.
- Published
- 2020
- Full Text
- View/download PDF
5. Restless Leg Syndrome in the Setting of Patients With End-Stage Renal Disease on Hemodialysis: A Literature Review
- Author
-
Shehnaz Wasim, Srikala Kambampati, Bilal Haider Malik, Vishal Kukkar, and Vanessa M Awad
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,End stage renal disease ,03 medical and health sciences ,0302 clinical medicine ,Atrophy ,uremic rls ,Internal medicine ,mental disorders ,medicine ,Internal Medicine ,restless leg syndrome ,hemodialysis ,Pramipexole ,business.industry ,General Engineering ,esrd ,medicine.disease ,Uremia ,Transplantation ,Ropinirole ,quality of life ,Nephrology ,Hemodialysis ,business ,030217 neurology & neurosurgery ,Family/General Practice ,medicine.drug ,Kidney disease - Abstract
Restless Leg Syndrome (RLS), or Willis-Ekbom disease (WED), is an irresistible urge to move the legs, predominantly while resting, sitting, or sleeping, which disrupts sleep and impairs quality of life. RLS can occur secondary to uremia in chronic kidney disease (CKD) patients due to inadequate hemodialysis. Early diagnosis is essential to prevent muscular atrophy and to improve the quality of life of RLS patients, especially those with end-stage renal disease (ESRD). Cardiac mortality high in uremic RLS patients due to associated discomfort and lowering the duration of hemodialysis treatment. This review focuses on and discusses the diagnosis, treatment, and associated comorbid conditions of uremic RLS. Though the exact pathophysiology is unknown, altered transferrin expression in the choroid plexus, increased glutamate levels in the thalamus, decreased opioid receptors, dopamine system dysfunction, calcium/phosphate imbalance, and single nucleotide polymorphisms in the BTBD9 and MEIS1 genes are a few nonconfirmatory pathophysiological concepts for uremic RLS. Nonpharmacological options include lowering the temperature of dialysate by 1 degree C and home-based therapies like massages, warm/cold baths, and aerobic exercises. Pharmacological therapy like dopamine agonists ropinirole and pramipexole reduces the symptoms effectively. However, surgical options like parathyroidectomy and renal transplantation are stated as the best treatment options in patients suffering from uremic RLS.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.